4.5 Article

The Effects of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy: An Open Label Quasi-Randomized Controlled Pilot Study

Journal

COMPLEMENTARY THERAPIES IN MEDICINE
Volume 56, Issue -, Pages -

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.ctim.2020.102587

Keywords

Aromatherapy; Chemotherapy; nursing; Nausea-Vomiting; Peppermint

Funding

  1. Unit of Scientific Research Projects of Erciyes University [TDK-2017-7305]

Ask authors/readers for more resources

The study evaluated the effects of peppermint oil on reducing nausea, vomiting, and the severity of nausea in cancer patients undergoing chemotherapy. The results showed that peppermint oil significantly decreased the frequency and severity of these symptoms, particularly in patients receiving specific chemotherapy treatments.
Objectives: The current study evaluated the effects of peppermint oil on the frequency of nausea, vomiting, retching, and the severity of nausea in cancer patients undergoing chemotherapy. Design: A quasi-randomized controlled study. Setting: Patients were recruited from the ambulatory chemotherapy unit of a public hospital located (Batman, Turkey) between September 2017 and September 2018. Interventions: The participants in the intervention group applied one drop the aromatic mixture on the spot between their upper lip and their nose, three times a day for the five days following chemotherapy administration, in addition to the routine antiemetic treatment. Participants in the control group underwent only the routine antiemetic treatment. Main outcome measures VAS-the severity of nausea and the Index of Nausea, Vomiting, and Retching. Results: The VAS nausea score was significantly lower after peppermint oil applying in the patients receiving Folfirinox (treatment effect (mean dif.): 4.00 +/- 2.28; P<0.001), Paclitaxel-Trastuzumab (treatment effect (mean dif.): 1.70 +/- 0.90; P=0.014), Carboplatin-Paclitaxel (treatment effect (mean dif.): 3.71 +/- 1.41; P<0.001), and Cyclophosphamide-Adriamycin (treatment effect (mean dif.): 1.41 +/- 0.73; P=0.005) excluding cisplatin scedule (treatment effect (mean dif.): 0.56 +/- 2,18; P=0.642). We detected a statistical significant difference in the change in frequency of nausea, vomiting, retching in the other all schedules excluding cisplatin schedule (P<0.05). Conclusions: The peppermint oil was significantly reduced the frequency of nausea, vomiting, retching and the severity of nausea in cancer patients undergoing chemotherapy. Therefore, usage of peppermint oil together with antiemetics after chemotherapy with moderate and low emetic risk may be recommended to cope with CINV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available